Accession Number: | 0000899866-15-000125 |
Date: | 2015-05-14 |
Issuer: | ALEXION PHARMACEUTICALS INC (ALXN) |
Original Submission Date: |
MACKAY MARTIN
C/O ALEXION PHARMACEUTICALS, INC
352 KNOTTER DRIVE
CHESHIRE, CT 06410
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK, PAR VALUE $.0001 PER SHARE | 2015-05-14 | S | 4,056 | d | $160.33 | 32,893 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | this sale was made to cover withholding taxes immediately following the vesting of previously granted restricted stock units. |